Researcher.Life Logo

Current Urology : Impact Factor & More

eISSN: 1661-7657pISSN: 1661-7649
JournalOpen Access

Key Metrics

CiteScore
2.5
H-Index
18
SJR
Q3Urology
SNIP
1.13
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Urology

Current Urology Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Quarterly
Publication Time24
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorShandong University
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 24
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Current Urology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Urology

Re: Patients with frailty, BPH and indwelling bladder catheter: What are the 1-year outcomes after Rezūm therapy?
  • 27 Oct 2025
  • Current Urology
Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features
  • 21 Oct 2025
  • Current Urology
The role of uropathogenic Escherichia coli biofilms in antibiotic-resistant urinary tract infections: Nanoparticle-based, phage therapy, and quorum-sensing inhibitor approaches
  • 2 Oct 2025
  • Current Urology
Tackling the progression of benign prostatic hyperplasia/benign prostatic obstruction progression: Deobstructing within the "window of curability" (a hypothesis-generating review).
  • 10 Sep 2025
  • Current urology
Clinical evaluation of combined programmed cell death protein 1 inhibitor and poly(ADP-ribose) polymerase inhibitor in metastatic castration-resistant prostate cancer patients: Insights from a real-world study.
  • 4 Sep 2025
  • Current urology
Chimeric antigen receptor-based cell therapy for treating urological tumors.
  • 29 Aug 2025
  • Current urology
Re: Patients with frailty, BPH and indwelling bladder catheter: What are the 1-year outcomes after Rezūm therapy?
  • 27 Oct 2025
  • Current Urology
Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features
  • 21 Oct 2025
  • Current Urology
The role of uropathogenic Escherichia coli biofilms in antibiotic-resistant urinary tract infections: Nanoparticle-based, phage therapy, and quorum-sensing inhibitor approaches
  • 2 Oct 2025
  • Current Urology
Tackling the progression of benign prostatic hyperplasia/benign prostatic obstruction progression: Deobstructing within the "window of curability" (a hypothesis-generating review).
  • 10 Sep 2025
  • Current urology
Clinical evaluation of combined programmed cell death protein 1 inhibitor and poly(ADP-ribose) polymerase inhibitor in metastatic castration-resistant prostate cancer patients: Insights from a real-world study.
  • 4 Sep 2025
  • Current urology
Chimeric antigen receptor-based cell therapy for treating urological tumors.
  • 29 Aug 2025
  • Current urology

FAQs on Current Urology